Special Supplement, Fall 2026

					View Special Supplement, Fall 2026

Fixed-Duration First-Line Therapy for Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) in Canada:
A Canadian Expert Clinical Framework

Published: 2026-11-12

Articles